164 related articles for article (PubMed ID: 29780514)
1. Construction of histidine-containing hydrocarbon stapled cell penetrating peptides for
Hyun S; Choi Y; Lee HN; Lee C; Oh D; Lee DK; Lee C; Lee Y; Yu J
Chem Sci; 2018 Apr; 9(15):3820-3827. PubMed ID: 29780514
[TBL] [Abstract][Full Text] [Related]
2. Hydrocarbon-Stapled Peptide Based-Nanoparticles for siRNA Delivery.
Simon M; Laroui N; Heyraud M; Laconde G; Ali LMA; Bourbiaux K; Subra G; Vezenkov LL; Legrand B; Amblard M; Bettache N
Nanomaterials (Basel); 2020 Nov; 10(12):. PubMed ID: 33255624
[TBL] [Abstract][Full Text] [Related]
3. An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery.
Oba M; Shibuya M; Yamaberi Y; Yokoo H; Uchida S; Ueda A; Tanaka M
Chem Pharm Bull (Tokyo); 2023; 71(3):250-256. PubMed ID: 36858531
[TBL] [Abstract][Full Text] [Related]
4. Magainin 2-derived stapled peptides derived with the ability to deliver pDNA, mRNA, and siRNA into cells.
Hirano M; Yokoo H; Goto C; Oba M; Misawa T; Demizu Y
Chem Sci; 2023 Oct; 14(38):10403-10410. PubMed ID: 37799999
[TBL] [Abstract][Full Text] [Related]
5. Engineered Histidine-Enriched Facial Lipopeptides for Enhanced Intracellular Delivery of Functional siRNA to Triple Negative Breast Cancer Cells.
Biswas A; Chakraborty K; Dutta C; Mukherjee S; Gayen P; Jan S; Mallick AM; Bhattacharyya D; Sinha Roy R
ACS Appl Mater Interfaces; 2019 Feb; 11(5):4719-4736. PubMed ID: 30628773
[TBL] [Abstract][Full Text] [Related]
6. Hydrocarbon staple constructing highly efficient α-helix cell-penetrating peptides for intracellular cargo delivery.
Li S; Zhang X; Guo C; Peng Y; Liu X; Wang B; Zhuang R; Chang M; Wang R
Chem Commun (Camb); 2020 Dec; 56(100):15655-15658. PubMed ID: 33355559
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel nanoparticle by dual modification with the pluripotential cell-penetrating peptide PepFect6 for cellular uptake, endosomal escape, and decondensation of an siRNA core complex.
Mitsueda A; Shimatani Y; Ito M; Ohgita T; Yamada A; Hama S; Gräslund A; Lindberg S; Langel Ü; Harashima H; Nakase I; Futaki S; Kogure K
Biopolymers; 2013 Nov; 100(6):698-704. PubMed ID: 23893316
[TBL] [Abstract][Full Text] [Related]
8. Rational modification of oligoarginine for highly efficient siRNA delivery: structure-activity relationship and mechanism of intracellular trafficking of siRNA.
Chu D; Xu W; Pan R; Ding Y; Sui W; Chen P
Nanomedicine; 2015 Feb; 11(2):435-46. PubMed ID: 25193363
[TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery.
Langlet-Bertin B; Leborgne C; Scherman D; Bechinger B; Mason AJ; Kichler A
Pharm Res; 2010 Jul; 27(7):1426-36. PubMed ID: 20393870
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficiency of complexes based on S4(13)-PV cell-penetrating peptides in plasmid DNA and siRNA delivery.
Cardoso AM; Trabulo S; Cardoso AL; Maia S; Gomes P; Jurado AS; Pedroso de Lima MC
Mol Pharm; 2013 Jul; 10(7):2653-66. PubMed ID: 23697649
[TBL] [Abstract][Full Text] [Related]
11. A retro-inverso cell-penetrating peptide for siRNA delivery.
Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
[TBL] [Abstract][Full Text] [Related]
12. Glycopolymer-Cell-Penetrating Peptide (CPP) Conjugates for Efficient Epidermal Growth Factor Receptor (EGFR) Silencing.
Peng YY; Hu H; Diaz-Dussan D; Zhao J; Hao X; Narain R
ACS Macro Lett; 2022 Apr; 11(4):580-587. PubMed ID: 35575337
[TBL] [Abstract][Full Text] [Related]
13. A novel peptide for efficient siRNA delivery in vitro and therapeutics in vivo.
Pan R; Xu W; Yuan F; Chu D; Ding Y; Chen B; Jafari M; Yuan Y; Chen P
Acta Biomater; 2015 Jul; 21():74-84. PubMed ID: 25861950
[TBL] [Abstract][Full Text] [Related]
14. Delivery of gene targeting siRNAs to breast cancer cells using a multifunctional peptide complex that promotes both targeted delivery and endosomal release.
Bjorge JD; Pang A; Fujita DJ
PLoS One; 2017; 12(6):e0180578. PubMed ID: 28666009
[TBL] [Abstract][Full Text] [Related]
15. siRNA-loaded poly(histidine-arginine)
Sun P; Huang W; Kang L; Jin M; Fan B; Jin H; Wang QM; Gao Z
Int J Nanomedicine; 2017; 12():3221-3234. PubMed ID: 28458542
[TBL] [Abstract][Full Text] [Related]
16. Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy.
Mo RH; Zaro JL; Shen WC
Mol Pharm; 2012 Feb; 9(2):299-309. PubMed ID: 22171592
[TBL] [Abstract][Full Text] [Related]
17. Liquid Crystalline Nanodispersions Functionalized with Cell-Penetrating Peptides for Topical Delivery of Short-Interfering RNAs: A Proposal for Silencing a Pro-Inflammatory Cytokine in Cutaneous Diseases.
Petrilli R; Eloy JO; Praça FS; Del Ciampo JO; Fantini MA; Fonseca MJ; Bentley MV
J Biomed Nanotechnol; 2016 May; 12(5):1063-75. PubMed ID: 27305826
[TBL] [Abstract][Full Text] [Related]
18. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
[TBL] [Abstract][Full Text] [Related]
19. Trileucine residues in a ligand-CPP-based siRNA delivery platform improve endosomal escape of siRNA.
Ullah I; Chung K; Beloor J; Kim J; Cho M; Kim N; Lee KY; Kumar P; Lee SK
J Drug Target; 2017 Apr; 25(4):320-329. PubMed ID: 27820977
[TBL] [Abstract][Full Text] [Related]
20. siRNA delivery using amphipathic cell-penetrating peptides into human hepatoma cells.
Furukawa K; Tanaka M; Oba M
Bioorg Med Chem; 2020 Apr; 28(8):115402. PubMed ID: 32146061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
